Sign In
test

Seth Berman

Ishara Investments Lp

Assets Managed
$105.625M
Holdings
36
Last Quarter
2026 - Q1
Filed Date
1mo 4d ago
Growth Rate
20.78%(2Q avg: 10.39%)
Sustained Growth
1 quarters

Portfolio positions

This chart displays the top 10 holdings in Ishara Investments Lp's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 36 positions.

Assets under management

The assets under management (AUM) of Ishara Investments Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 105.625M in assets, with a quarterly growth rate of 20.78% and a 2-quarter average growth rate of 10.39%. The portfolio is managed by Seth Berman, and others.

Portfolio holdings

InvestmentPortfolio %Reported Value
PRAX
Praxis Precision Medicines I
Recent Activity
Increased 7.63%
13.14%
$13.87M
43,050 shares@ $322.2 avg price
AXSM
Axsome Therapeutics Inc
Recent Activity
New Position
6.57%
$6.93M
41,000 shares@ $169.02 avg price
XERS
Xeris Biopharma Holdings Inc
Recent Activity
Increased 28.13%
5.63%
$5.945M
1.025M shares@ $5.8 avg price
KALV
Kalvista Pharmaceuticals Inc
Recent Activity
New Position
5.28%
$5.571M
276,750 shares@ $20.14 avg price
FOLD
Amicus Therapeutics Inc
Recent Activity
Increased 2.5%
5.06%
$5.336M
369,000 shares@ $14.46 avg price
BMRN
Biomarin Pharmaceutical Inc
Recent Activity
Decreased -18%
4.39%
$4.632M
82,000 shares@ $56.49 avg price
VSTM
Verastem Inc
Recent Activity
Increased 203.71%
4.12%
$4.346M
820,000 shares@ $5.3 avg price
RARE
Ultragenyx Pharmaceutical In
Recent Activity
Increased 248.5%
3.46%
$3.651M
174,250 shares@ $20.96 avg price
ARWR
Arrowhead Pharmaceuticals In
Recent Activity
New Position
3.29%
$3.47M
55,350 shares@ $62.7 avg price
PCVX
Vaxcyte Inc
Recent Activity
Increased 14.8%
3.16%
$3.336M
57,400 shares@ $58.11 avg price

1-10 of 36